Semiselective immunoadsorption of anti-AChR abs on tryptophan column in myasthenia gravis. Clinical experience in 32 patients

Heininger, 1985, Myasthenia gravis: a new semiselective procedure to remove acetylcholine receptor autoantibodies for plasma, Plasma Ther Transfus Technol, 6, 771 Heininger, 1986, Selective removal of pathogenic factors in neurologic disease, Plasma Ther Transfus Technol, 7, 351 Heininger, 1987, Therapeutic plasma exchange in myasthenia gravis: semiselective adsorption of anti-AChR autoantibodies with tryptophan-linked polyvinylalcohol gels, Ann NY Acad Sci, 505, 898, 10.1111/j.1749-6632.1987.tb51406.x Heininger, 1987, Selective removal of antibodies: Theoretical and practical aspects, 136 Sato, 1983, Selective removal of anti-acetylcholine receptor antibodies in sera from patients with myasthenia gravis in vitro with a new immunosorbent, 565 Sato, 1988, Therapeutic immunoadsorption of AChR antibodies in MG, Ann NY Acad Sci, 540 Shibuya, 1987, Immunoadsorption therapy in neurologic diseases: Myasthenia gravis, multiple sclerosis, and Guillain-Barré syndrome, 122 Toyka, 1981, Myasthenia gravis: the pathogenic role of antibodies to acetylcholine receptor and the effect of antibody depletion, 172 Yamazaki, 1982, Efficiency and biocompatibility of a new immunosorbent, Trans Am Soc Artif Intern Organs, 28, 318 Yamazaki, 1983, Basic studies on hemoperfusion immunoadsorption system with an immunoadsorbent (I-02), 141